Species-Specific Actions of Incretin: From the Evolutionary Perspective

Two modes of incretin-based therapy, incretin mimetics (ie, glucagon-like peptide-1 (GLP-1) agonists) and incretin enhancers (ie, inhibitors of dipeptidyl peptidase IV (DPP-IV)), have recently been introduced into the clinical use. From the viewpoint of evolutionary endocrinology of GLP-1 and their...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawasaki, Yukiko, Hamamoto, Yoshiyuki, Koshiyama, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2010
Materias:
Short Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738467/
https://www.ncbi.nlm.nih.gov/pubmed/23946675
http://dx.doi.org/10.4137/JCM.S5915

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738467/
https://www.ncbi.nlm.nih.gov/pubmed/23946675
http://dx.doi.org/10.4137/JCM.S5915

Ejemplares similares